Reactivity of a lecithin-free cardiolipin preparation (cardchol) in leprosy sera

Insights

Cardchol, a cardiolipin-cholesterol antigen, shows high reactivity with leprosy sera and false-positive reactors in complement-fixation tests. It is less reactive in syphilis, except for primary syphilis.

Area of Science:

  • Immunology
  • Clinical Chemistry

Background:

  • The complement-fixation test is a serological assay used for diagnosing infections.
  • Lipoidal antigens, such as cardiolipin, are commonly employed in these tests.

Purpose of the Study:

  • To evaluate the reactivity of a novel cardiolipin-cholesterol antigen (cardchol) compared to a standard cardiolipin antigen (CWRM).
  • To assess the diagnostic utility of cardchol in distinguishing between syphilis, leprosy, and false-positive reactors.

Main Methods:

  • Complement-fixation tests were performed using both cardchol and CWRM antigens.
  • Sera from patients with syphilis, leprosy, and healthy individuals were analyzed.
  • Quantitative antibody levels were determined.
  • Electrophoretic fractionation was used to identify reacting serum components.

Main Results:

  • Cardchol demonstrated significantly higher reactivity with sera from leprosy patients and false-positive reactors compared to CWRM.
  • In syphilis cases, cardchol showed lower reactivity than CWRM, with an exception for primary syphilis.
  • Lepromatous leprosy, especially of shorter duration, showed the highest cardchol reactivity.
  • Reactive substances in leprosy sera were primarily located in gamma-globulin and beta-globulin fractions.

Conclusions:

  • Cardchol serves as a valuable antigen for differentiating leprosy and syphilis, and identifying false-positive reactors.
  • Its distinct reactivity profile offers potential for improved serological diagnostics in infectious diseases.